To get around these safety concerns and to potentially maximize therapeutic effects on tumors, Alvey and colleagues took fresh, young
macrophages from human donors as well as mouse donors and directly blocked their SIRPA.
Not exact matches
«Our new approach takes young and aggressive
macrophages from the bone marrow of a
human donor and removes a key safeguard that cancer cells have co-opted to prevent them
from being engulfed,» Alvey said.